The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed, most often in Biotech.
Corporate venture armBoston, MA, USAnybcventures.comRounds from 2024-10-22 to 2026-10-22
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
STAR Therapeutics They develop and provide antibody therapies for patients with serious diseases. | Funding round Verified against 1 of 9 sources | $200M | 2026-10-22 | [ PART ] |
AvenCell Therapeutics A privately held clinical-stage company developing CAR-T therapies | Series B |
| $112M |
| 2024-10-22 |
| [ PART ] |